EMVision shares lift after Ramsay Health Care CEO Carmel Monaghan joins board
Make us a preferred source
Make us a preferred source on Google
The news: Portable brain scanner manufacturer EMvision Medical Devices has seen its share price lift after announcing today that Ramsay Health Care CEO Carmel Monaghan has joined its board.
The numbers: By late morning, EMVision shares had risen 3.5% to $1.76 at 10:29am AEST.
The context: Monaghan has been Ramsay CEO since 2020 and has spent more than 27 years across the business.
This includes as group chief of staff for Ramsay’s global operations and as group head of marketing and public affairs.
She joins EMVision as a non-executive director.
What they said: “I’m delighted to join the board of EMVision and look forward to working with management and fellow directors as the company enters a pivotal phase in its commercialisation journey,” Monaghan said.
EMVision chairman John Keep noted that with the company’s “pivotal trial for regulatory clearance underway, the board looks forward to Carmel’s contributions as EMVision progresses through to commercialisation and growth”.
The source: ASX
